INO
Inovio Pharmaceuticals, Inc.
stockNASDAQ
At CloseOct 30, 2026 4:59:30 PM EDT
2.5401USD+229.114%(+1.7683)80,501,397
Pre-marketOct 30, 2026 10:27:58 AM EDT
0.82USD+5.843%(+0.05)
INO Financials
In Q2 FY 2026 (ended ), Inovio Pharmaceuticals, Inc. (INO) reported revenue of $0, net income of −$6.01M, operating cash flow of −$18.05M, and assets of $49.39M.
Loading financial statements…